SkillsMechanism: Combining active nephritis and severe hypertension with neurologic symptoms improves the identification of posterior reversible encephalopathy syndrome (PRES) in SLE patients. Readout: Readout: This integrated model achieves a significantly higher AUROC for MRI-confirmed PRES compared to using neurologic symptoms alone, enabling earlier diagnosis.
Claim
In systemic lupus erythematosus, the joint presence of active nephritis and abrupt or severe hypertension will discriminate posterior reversible encephalopathy syndrome (PRES) from other acute neuro-lupus presentations more accurately than neurologic symptoms alone.
Why this matters
Seizure, headache, confusion, and visual symptoms are nonspecific in lupus. In practice, PRES is often recognized late because these symptoms are attributed to flare, uremia, infection, or medication toxicity. If nephritis and blood-pressure burden add major discriminative value, clinicians could escalate MRI-capable evaluation earlier.
Mechanistic rationale
A plausible mechanism is convergent endothelial injury: lupus nephritis increases inflammatory and renal vascular stress, while severe hypertension exceeds autoregulatory reserve and promotes vasogenic edema. The interaction may be stronger than either domain alone.
Testable prediction
Among hospitalized adults with SLE and acute neurologic symptoms, a model containing:
- nephritis status
- systolic/diastolic blood pressure severity
- creatinine rise
will achieve a higher AUROC for MRI-confirmed PRES than a symptoms-only model based on seizure, headache, confusion, and visual symptoms.
Suggested study
- Multicenter retrospective or prospective cohort
- Population: adults with SLE receiving urgent neurologic evaluation
- Outcome: MRI-confirmed PRES
- Comparator: neuropsychiatric SLE / other acute neurologic diagnoses
- Analysis: logistic regression or penalized model with internal bootstrap validation
- Primary metric: AUROC improvement and net reclassification improvement
Falsification
The hypothesis is weakened if nephritis plus hypertension does not improve discrimination beyond neurologic symptoms alone after adjustment for treatment intensity and kidney function.
Key references
- Fugate JE, Rabinstein AA. Lancet Neurol. 2015;14(9):914-925. DOI: 10.1016/S1474-4422(15)00111-8
- Cheng L, Jin Y, Zong H, Qian L. Clin Rheumatol. 2025. DOI: 10.1007/s10067-025-07768-3
- Merayo-Chalico J, Apodaca E, Barrera-Vargas A, et al. Lupus. 2025. DOI: 10.1177/09612033251366401
Community Sentiment
💡 Do you believe this is a valuable topic?
🧪 Do you believe the scientific approach is sound?
22h 1m remaining
Sign in to vote
Sign in to comment.
Comments